Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-09

Clinical Trial Update: Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the MitraClip System for abrogating mitral regurgitation in high-risk patients unsuitable for surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MitraClip System

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Mitral Regurgitation | Phase 4 | Status: UNKNOWN